Literature DB >> 2226622

The hypotensive and negative chronotropic effects of dehydroevodiamine.

M C Yang1, S L Wu, J S Kuo, C F Chen.   

Abstract

The cardiovascular effects of dehydroevodiamine, an alkaloid isolated from Evodia rutaecarpa Jussieu, were studied in both in vivo and in vitro experiments. The in vivo experiments revealed that i.v. administration of dehydroevodiamine elicited a slight but significant reduction in blood pressure and a marked decrease in heart rate which was confirmed by an increased cycle length of the electrocardiogram. However, a hemodynamic experiment with microspheres showed that the total peripheral resistance was not altered by dehydroevodiamine. The blood flows of various organs were not significantly changed except those of kidney and skin, in which blood flow was decreased. In vitro, the spontaneously beating atria were significantly suppressed by dehydroevodiamine in a dose-dependent manner. These findings suggested an important effect of dehydroevodiamine in suppressing the heart, which may largely contribute to the hypotensive effect of this alkaloid. However, its vasodilator effect on hindquarter muscles cannot be neglected.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2226622     DOI: 10.1016/0014-2999(90)90052-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Effects of dehydroevodiamine exposure on glutamate release and uptake in the cultured cerebellar cells.

Authors:  Dong Koo Lim; Yong Bok Lee; Han Soo Kim
Journal:  Neurochem Res       Date:  2004-02       Impact factor: 3.996

2.  Ionic mechanisms responsible for the antiarrhythmic action of dehydroevodiamine in guinea-pig isolated cardiomyocytes.

Authors:  S H Loh; A R Lee; W H Huang; C I Lin
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

3.  Dehydroevodiamine·HCl enhances cognitive function in memory-impaired rat models.

Authors:  Ki Young Shin; Ka Young Kim; Yoo-Hun Suh
Journal:  Korean J Physiol Pharmacol       Date:  2016-12-21       Impact factor: 2.016

Review 4.  Pharmacological actions of multi-target-directed evodiamine.

Authors:  Hui Yu; Hongwei Jin; Wuzhuang Gong; Zhanli Wang; Huaping Liang
Journal:  Molecules       Date:  2013-01-31       Impact factor: 4.411

Review 5.  HPLC-based activity profiling for pharmacologically and toxicologically relevant natural products - principles and recent examples.

Authors:  Matthias Hamburger
Journal:  Pharm Biol       Date:  2019-12       Impact factor: 3.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.